Potential and limits of cannabinoids in Alzheimer's disease therapy
Simple Summary This review was aimed at exploring the potentiality of drugging the
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …
endocannabinoid system as a therapeutic option for Alzheimer's disease (AD). Recent …
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic
E Aso, I Ferrer - Frontiers in pharmacology, 2014 - frontiersin.org
The limited effectiveness of current therapies against Alzheimer's disease (AD) highlights
the need for intensifying research efforts devoted to developing new agents for preventing or …
the need for intensifying research efforts devoted to developing new agents for preventing or …
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease
Alzheimer's disease (AD) is a debilitating neurodegenerative disease characterized by
declining cognition and behavioral impairment, and hallmarked by extracellular amyloid-β …
declining cognition and behavioral impairment, and hallmarked by extracellular amyloid-β …
The therapeutic potential of the endocannabinoid system for Alzheimer's disease
Introduction: Dementia currently affects over 35 million people worldwide. The most common
form of dementia is Alzheimer's disease (AD). Currently, treatments for AD do not stop or …
form of dementia is Alzheimer's disease (AD). Currently, treatments for AD do not stop or …
[HTML][HTML] Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?
MB Viana, PEA Aquino, D Estadella… - Medical Cannabis and …, 2022 - karger.com
This work is a literature review, presenting the current state of the use of cannabinoids on
neurodegenerative diseases. The emphasis is on Parkinson's (PD) and Alzheimer's (AD) …
neurodegenerative diseases. The emphasis is on Parkinson's (PD) and Alzheimer's (AD) …
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by
progressive loss of cognition. Over 35 million individuals currently have AD worldwide …
progressive loss of cognition. Over 35 million individuals currently have AD worldwide …
Recent advances in the potential of cannabinoids for neuroprotection in Alzheimer's, Parkinson's, and Huntington's diseases
Three prevalent neurodegenerative diseases, Parkinson's, Alzheimer's, and Huntington's
are in need of symptomatic relief of slowing disease progression or both. This chapter …
are in need of symptomatic relief of slowing disease progression or both. This chapter …
Emerging promise of cannabinoids for the management of pain and associated neuropathological alterations in Alzheimer's disease
MS Uddin, AA Mamun, DM Sumsuzzman… - Frontiers in …, 2020 - frontiersin.org
Alzheimer's disease (AD) is an irreversible chronic neurodegenerative disorder that occurs
when neurons in the brain degenerate and die. Pain frequently arises in older patients with …
when neurons in the brain degenerate and die. Pain frequently arises in older patients with …
Cannabinoids in late‐onset Alzheimer's disease
AIA Ahmed, MA Van Der Marck… - Clinical …, 2015 - Wiley Online Library
Given the lack of effective treatments for late‐onset Alzheimer's disease (LOAD) and the
substantial burden on patients, families, health care systems, and economies, finding an …
substantial burden on patients, families, health care systems, and economies, finding an …
[HTML][HTML] Phytocannabinoids and cannabis-based products as alternative pharmacotherapy in neurodegenerative diseases: From hypothesis to clinical practice
Y Paes-Colli, AFL Aguiar, AR Isaac… - Frontiers in cellular …, 2022 - frontiersin.org
Historically, Cannabis is one of the first plants to be domesticated and used in medicine,
though only in the last years the amount of Cannabis-based products or medicines has …
though only in the last years the amount of Cannabis-based products or medicines has …